Пошук по сайту
Авторизація
Логин:
Пароль:
Регистрация
Забыли свой пароль?
Періодика
Медична інформатика та інженерія
Партнери
Поиск информации по диагнозу / Med And Me Первый украинский нефрологический сайт проф. Д. Иванова Zepter
Технічна підтримка

Європейські ринки несудинних стентів (European Markets for Nonvascular Stents)




In recent years, there have considerable advances both in product design and materials used for all forms of nonvascular stents. Significant changes in the structure and design of nonvascular stents have been made through proprietary technologies, which have helped prevent stent migration and improve flexibility. In 2010, nonvascular stents (including biliary, esophageal, trachobronchial, and urologic) stents were used in more than 56,550 interventional procedures in the countries covered by this report (France, Germany, Italy, Spain, and the United Kingdom), generating nearly $93 million in associated product sales. Over the forecast period covered by this report, the number of nonvascular stenting procedures performed in Europe is expected to increase at a 3.1% growth rate, reaching nearly 65,790 in the year 2015; during the same period, corresponding dollar sales are expected to increase at a 6.4% growth rate, reaching approximately $126 million in the year 2015.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European nonvascular stents market. Major topics covered by this report include a discussion of current and emerging nonvascular stenting technologies; a clinical overview of nonvascular conditions targeted by stenting, and an analysis of the European markets for biliary, esophageal, tracheobronchial, and urologic (including ureteral and urethral/prostatic) stents.

TABLE OF CONTENTS

EXECUTIVE SUMMARY


i. Stent Design
ii. Procedure Volumes
iii. Market Analysis

a. Biliary Stents
b. Esophageal Stents
c. Tracheobronchial Stents
d. Urologic Stents
e. Combined Market Forecast

Exhibit ES-1: Europe, Nonvascular Stent Placements, Combined Procedure Volumes Forecast, 2010-2015
Exhibit ES-2: Europe, Nonvascular Stents, Combined Market Forecast, 2010-2015

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

1.1 Stent Design
1.1.1 Vascular Stents
1.1.2 Nonvascular Stents
1.1.3 Stent Deployment Mechanisms
1.2 Stent Materials
1.2.1 Metal
1.2.1.1 Absorbable Magnesium Alloys
1.2.1.2 Cobalt Alloys
1.2.1.3 Nickel-Titanium Alloys
1.2.1.4 Stainless Steel
1.2.2 Standard Polymers
1.2.3 Biodegradable Polymers
1.3 Stent Coatings
1.3.1 Radiopacity Enhancement
1.3.2 Biocompatibility Enhancement
1.3.3 Active Therapeutic Enhancement
1.3.3.1 Drug-Eluting Stents
1.3.3.1.1 Antirestenotic Efficacy
1.3.3.1.2 Drug Delivery Techniques
1.3.4 Stent Coverings and Linings
Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements
Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs
Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials
Exhibit 1-4: Selected Polymeric Stent Materials
Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents
Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents

2. OVERVIEW OF STENTING FOR NONVASCULAR APPLICATION

2.1 Bile Duct Diseases
2.1.1 Benign Biliary Strictures
2.1.2 Malignant Biliary Strictures
2.1.3 Treatment
2.2 Esophageal Diseases
2.2.1 Benign Esophageal Strictures
2.2.2 Malignant Esophageal Strictures
2.2.3 Treatment
2.2.3.1 Nonsurgical Treatment
2.2.3.2 Surgical Treatment
2.3 Renal System Diseases
2.3.1 Benign Urethral and Prostatic Strictures
2.3.2 Malignant Urethral and Prostatic Strictures
2.3.3 Treatment
2.4 Tracheobronchial System Diseases
2.4.1 Benign Tracheobronchial Strictures
2.4.2 Malignant Tracheobronchial Strictures
2.4.3 Treatment
2.4.3.1 Expandable Metal Stents
2.4.3.2 Silicone Stents
3. EUROPEAN NONVASCULAR STENTS MARKET

3.1 Biliary Stents
3.1.1 Products and Technologies
3.1.2 Market Analysis
3.1.3 Competitive Analysis
3.2 Esophageal Stents
3.2.1 Products and Technologies
3.2.2 Market Analysis
3.2.3 Competitive Analysis
3.3 Tracheobronchial Stents
3.3.1 Products and Technologies
3.3.2 Market Analysis
3.3.3 Competitive Analysis
3.4 Urologic Stents
3.4.1 Products and Technologies
3.4.1.1 Ureteral Stents
3.4.1.2 Urethral (or Prostatic) Stents
3.4.2 Market Analysis
3.4.3 Competitive Analysis
3.5 Combined Market Analysis
3.5.1 Market Drivers
3.5.2 Market Limiters
3.5.3 Combined Market Forecast
Exhibit 3-1: 2012, Europe, Selected Biliary Stents
Exhibit 3-2: Europe, Biliary Stent Placements, Procedure Volumes Forecast, 2010-2015
Exhibit 3-3: Europe, Biliary Stents, Market Forecast, 2010-2015
Exhibit 3-4: 2010, Europe, Biliary Stents Market, Share by Supplier
Exhibit 3-5: 2012, Europe, Selected Esophageal Stents
Exhibit 3-6: Europe, Esophageal Stent Placements, Procedure Volumes Forecast, 2010-2015
Exhibit 3-7: Europe, Esophageal Stents, Market Forecast, 2010-2015
Exhibit 3-8: 2010, Europe, Esophageal Stents Market, Share by Supplier
Exhibit 3-9: Advantages and Disadvantages of Metal and Silicone Tracheobronchial Stents
Exhibit 3-10: 2012, Europe, Selected Tracheobronchial Stents
Exhibit 3-11: Europe, Tracheobronchial Stent Placements, Procedure Volumes Forecast, 2010-2015
Exhibit 3-12: Europe, Tracheobronchial Stents, Market Forecast, 2010-2015
Exhibit 3-13: 2010, Europe, Tracheobronchial Stents Market, Share by Supplier
Exhibit 3-14: 2012, Europe, Selected Urologic Stents
Exhibit 3-15: Europe, Urologic Stent Placements, Procedure Volumes Forecast, 2010-2015
Exhibit 3-16: Europe, Urologic Stents, Market Forecast, 2010-2015
Exhibit 3-17: 2010, Europe, Urologic Stents Market, Share by Supplier
Exhibit 3-18: Europe, Nonvascular Stent Placements, Combined Procedure Volumes Forecast, 2010-2015
Exhibit 3-19: Europe, Nonvascular Stents, Combined Market Forecast, 2010-2015

4. COMPANY PROFILES

4.1 Abbott Laboratories
4.2 C.R. Bard, Inc.
4.3 Boston Scientific Corporation
4.4 Cook Group, Inc.
4.5 ev3, Inc./Covidien, Inc.
4.6 W.L. Gore & Associates, Inc.
4.7 Johnson & Johnson
4.8 Medtronic, Inc.

Publisher: Medtech Insight
Перекладач: translate.google.com
Європейські ринки несудинних стентів (European Markets for Nonvascular Stents)
Американські ринки не судинних стентів (U.S. Markets for Nonvascular Stents)
Новини
29.09.2020   Селера: корисні властивості і протипоказання
28.09.2020  Вчені виявили, що відмова від продуктів з борошна сприяє покращенню стану людей, хворих на екзему
25.09.2020  Що можна і не можна їсти для поліпшення засвоєння заліза організмом
24.09.2020  Продукти, які допоможуть привести холестерин в норму і захистити від серцево-судинних захворювань
23.09.2020  Як впоратися з підвищеним апетитом восени: корисні поради
22.09.2020  Експерти виявили овоч, який здатний знижувати рівень поганого холестерину у крові
21.09.2020  Які люди найбільше реагують на перепади погоди, та як з цим боротися — поради лікарів
18.09.2020  Якими побічними ефектами володіє чай при його надмірному вживанні
17.09.2020  Три неочікувані ознаки того, що ваша печінка повна токсинів
16.09.2020  Вчені виявили ще один фактор, який здатен провокувати розвиток діабету другого типу
15.09.2020  Топ-5 вітамінів, нестача яких заважає вам засинати
14.09.2020  Ефективні поради, які допоможуть зняти сильне відчуття постійної втоми
11.09.2020  Чому на сніданок варто вживати клітковину
10.09.2020  6 вагомих приводів мати серед спецій вдома корицю
09.09.2020  Ці 6 ознак можуть вказувати на розвиток "тихої" пневмонії
08.09.2020  Яка олія приносить більше користі організму: соняшникова чи оливкова
07.09.2020   Чим корисна м'ята для здоров'я людини
04.09.2020  Кілька сигналів від організму, що говорять про проблеми з серцем
03.09.2020  Чому восени варто переглянути свій раціон
02.09.2020  Вчені пояснили, чому денний сон шкідливий для здоров'я
HINARI
PubMed